tiprankstipranks
Trending News
More News >
OncoArendi Therapeutics SA (DE:1B1)
FRANKFURT:1B1
Germany Market

OncoArendi Therapeutics SA (1B1) Technical Analysis

Compare
0 Followers

Summary of all the Indicators

Overall Consensus
Sell
8Bullish
1Neutral
13Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
OncoArendi Therapeutics SA’s (1B1) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting OncoArendi Therapeutics SA is a Buy.
OncoArendi Therapeutics SA’s (1B1) 20-Day exponential moving average is 1.72, while OncoArendi Therapeutics SA’s (1B1) share price is €1.63, making it a Sell.
OncoArendi Therapeutics SA’s (1B1) 50-Day exponential moving average is 1.70, while OncoArendi Therapeutics SA’s (1B1) share price is €1.63, making it a Sell.

OncoArendi Therapeutics SA (1B1) Pivot Points

Mar 09, 2026, 11:50 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.67
1.67
1.67
1.67
1.67
1.67
1.67
Fibonacci
1.67
1.67
1.67
1.67
1.67
1.67
1.67
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

OncoArendi Therapeutics SA (1B1) Moving Averages

Mar 09, 2026, 11:50 PM
Period
Simple
Exponential
MA5
1.70Sell
1.69Sell
MA10
1.74Sell
1.71Sell
MA20
1.73Sell
1.72Sell
MA50
1.69Sell
1.70Sell
MA100
1.63Buy
1.67Sell
MA200
1.61Buy
1.68Sell
OncoArendi Therapeutics SA’s (1B1) 10-Day exponential moving average is 1.71, while OncoArendi Therapeutics SA’s (1B1) share price is €1.63, making it a Sell.
OncoArendi Therapeutics SA’s (1B1) 100-Day exponential moving average is 1.67, while OncoArendi Therapeutics SA’s (1B1) share price is €1.63, making it a Sell.
OncoArendi Therapeutics SA’s (1B1) stock price is €1.63 and OncoArendi Therapeutics SA’s (1B1) 50-day simple moving average is 1.69, creating a Sell signal.
OncoArendi Therapeutics SA’s (1B1) stock price is €1.63 and OncoArendi Therapeutics SA’s (1B1) 100-day simple moving average is 1.63, creating a Buy signal.
OncoArendi Therapeutics SA’s (1B1) stock price is €1.63 and OncoArendi Therapeutics SA’s (1B1) 200-day simple moving average is 1.61, creating a Buy signal.

OncoArendi Therapeutics SA (1B1) Technical Indicators

Mar 09, 2026, 11:50 PM
Name
Value
Implied Action
RSI (14)
39.73
Neutral
STOCH (9,6)
-0.82
Buy
STOCHRSI (14)
-0.82
Buy
MACD (12,26)
>-0.01
Buy
ADX (14)
12.50
Buy
Williams %R
-102.47
Buy
CCI (14)
-123.22
Buy
ATR (14)
0.03
-
Ultimate Oscillator
17.03
Sell
ROC
-2.98
Sell
OncoArendi Therapeutics SA’s (1B1) Relative Strength Index (RSI) is 39.73, creating a Neutral signal.
OncoArendi Therapeutics SA’s (1B1) Trend Strength Indicator (ADX) is 12.50, creating a Buy signal.
OncoArendi Therapeutics SA’s (1B1) Commodity Channel Index (CCI) is -123.22, creating a Buy signal.
OncoArendi Therapeutics SA’s (1B1) Price Rate of Change (ROC) is -2.98, creating a Sell signal.

FAQ

Is 1B1 a Buy, Hold, or Sell?
Based on 1B1’s technical indicators, 1B1 is a Sell.
    What is 1B1’s RSI (14)?
    1B1’s RSI (14) is 39.73, which suggests 1B1 is a Neutral.
      What is 1B1’s MACD?
      1B1’s MACD is >-0.01, which suggests 1B1 is a Buy.
        What is 1B1’s 5-day moving average?
        1B1’s 5-day moving average is 1.70, which suggests 1B1 is a Sell.
          What is 1B1’s 20-day moving average?
          1B1 20-day moving average is 1.73, which suggests 1B1 is a Sell.
            What is 1B1’s 50-day moving average?
            1B1’s 50-day moving average is 1.69, which suggests 1B1 is a Sell.
              What is 1B1’s 200-day moving average?
              1B1’s 200-day moving average is 1.61, which suggests 1B1 is a Buy.
                What is 1B1’s Williams % R (14)?
                1B1’s Williams % R (14) is -102.47, which suggests 1B1 is a Buy.
                  What is 1B1’s CCI (14)?
                  1B1’s CCI (14) is -123.22, which suggests 1B1 is a Buy.
                    What is the share price of OncoArendi Therapeutics SA?